GES is a leading manufacturer of therapeutic cannabis products derived from medical-grade cannabis flowers, meticulously designed for pharmaceutical applications. Our state-of-the-art facility specializes in extracting and purifying primary bulk cannabinoids, including Δ9-THC and CBD, sourced from our trusted network of high-quality cultivators. Driven by extensive research and development programs, we've developed proprietary, chemo-type-specific API formulations that align with the therapeutic potential of medical cannabis. Our manufacturing processes adhere to strict pharmaceutical Good Manufacturing Practice (GMP) standards and incorporate advanced pharmaceutical manufacturing technologies to ensure consistency and standardization. At GES, we harness nature's abundant active therapies and refine them through modern scientific discoveries, delivering innovative, reliable, and effective therapeutic cannabis solutions.
| Website | http://www.geslabs.com |
| Employees | 61 (46 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Therapeutic Cannabis, Cannabis Flower, Cannabis Products, Medical Cannabis, Pharmaceutical Applications, Pharmaceutical Cannabis, Cannabis Extraction, Cannabis Concentrates, Cannabis Extracts, Bulk Cannabis, Cannabinoid Production, Cannabis Manufacturing, Plant Based Medicine, Natural Therapeutics, Alternative Medicine, Herbal Remedies, Holistic Healthcare |
| Competitors | Mayo Clinic Laboratories, Quest Diagnostics, Labcorp, BioReference Laboratories, ARUP Laboratories, PathGroup, Sonora Quest Laboratories/ Laboratory Sciences of Arizona, Clinical Pathology Laboratories, Sonic Healthcare, helen devos childrens hospital +28 more (view full list) |
Looking for a particular GESLabs employee's phone or email?
Peter Nel is the Founder, Director, President of GESLabs.
46 people are employed at GESLabs.
GESLabs is based in London, England.